ScholarIQanswers from OpenAlex & ORCID
David M. Kent
ResearcherPublications, citations & collaboration network
David M. Kent is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David M. Kent have?
ScholarIQindexed works
David M. Kent has 470 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David M. Kent have?
ScholarIQcitation count
David M. Kent has 18,558 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David M. Kent?
ScholarIQh-index
David M. Kent has an h-index of 72 in OpenAlex.
What is the i10-index of David M. Kent?
ScholarIQi10-index
David M. Kent has an i10-index of 227 in OpenAlex.
What is the ORCID of David M. Kent?
ScholarIQorcid
The ORCID for David M. Kent is on the source record.
What is the OpenAlex record for David M. Kent?
ScholarIQopenalex
The OpenAlex for David M. Kent is on the source record.
What are the most-cited papers on David M. Kent?
ScholarIQmost cited works
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
David M. Kent, Peter M. Rothwell, John P. A. Ioannidis, Doug Altman, Rodney A. Hayward
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement
David M. Kent, Jessica K. Paulus, David van Klaveren, Ralph B. D’Agostino, Steven N. Goodman, Rodney A. Hayward, John P. A. Ioannidis, Bray Patrick‐Lake, Sally C. Morton, Michael Pencina, Gowri Raman, Joseph S. Ross, Harry P. Selker, Ravi Varadhan, Andrew J. Vickers, John B. Wong, Ewout W. Steyerberg
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration
David M. Kent, David van Klaveren, Jessica K. Paulus, Ralph B. D’Agostino, Steven N. Goodman, Rodney A. Hayward, John P. A. Ioannidis, Bray Patrick‐Lake, Sally C. Morton, Michael Pencina, Gowri Raman, Joseph S. Ross, Harry P. Selker, Ravi Varadhan, Andrew J. Vickers, John B. Wong, Ewout W. Steyerberg
Progression Risk, Urinary Protein Excretion, and Treatment Effects of Angiotensin-Converting Enzyme Inhibitors in Nondiabetic Kidney Disease
David M. Kent, Tazeen H. Jafar, Rodney A. Hayward, Hocine Tighiouart, Marcia Landa, Paul de Jong, Dick de Zeeuw, Giuseppe Remuzzi, Anne‐Lise Kamper, Andrew S. Levey